Contact: Bryan Goodman, (202) 997-1606
Email: [email protected]
WASHINGTON (March 13, 2015) – Today members of the UN Commission on Narcotic Drugs unanimously rejected the recommendation from the World Health Organization to list 1,4-butanediol (BDO) and gamma-butyrolactone (GBL) as Schedule I substances under the 1971 Convention on Psychotropic Substances. In response to these developments, the American Chemistry Council released the following statement.
“The UN Commission on Narcotic Drugs has unanimously rejected the recommendation from the WHO to list the industrial chemicals GBL and BDO as Schedule I substances under the 1971 Convention on Psychotropic Substances. In fact, the 53 delegates unanimously agreed to not even bring the matter to a formal vote. As the delegates noted, such a classification would have severe economic consequences, disrupt many crucial industries, and affect country development agendas across the global economy.
“We support this decision in recognition of the strong product stewardship initiatives and controls that ACC member companies already have in place for these substances.”
Leave a Reply